SMAR1 inhibits proliferation, EMT and Warburg effect of bladder cancer cells by suppressing the activity of the Wnt/β-catenin signaling pathway

References

• Li J, Huang S, Zhang Y, et al. LINC00460 enhances bladder carcinoma cell proliferation and migration by modulating miR-612/FOXK1 axis. Pharmacology. 2021;106(1–2):79–90. DOI:10.1159/000509255
   PubMed Web of Science ®Google Scholar
• Zhou Q, Yu J, Zheng Q, et al. Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells in vitro and in vivo. FEBS Open Bio. 2021;11(5):1487–1496. DOI:10.1002/2211-5463.12768
   PubMed Web of Science ®Google Scholar
• Zhang Z, Chen F, Zhan H, et al. lncRNA CASC9 sponges miR‑758‑3p to promote proliferation and EMT in bladder cancer by upregulating TGF‑β2. Oncol Rep. 2021;45(1):265–277. DOI:10.3892/or.2020.7852
   PubMed Web of Science ®Google Scholar
• Li Y, et al. microRNA-27b inhibits cell proliferation and invasion in bladder cancer by targeting engrailed-2. Biosci Rep. 2021;41(1):BSR20201000.
   PubMed Web of Science ®Google Scholar
• Tang C, Wu Y, Wang X, et al. LncRNA MAFG-AS1 regulates miR-125b-5p/sphk1 axis to promote the proliferation, migration, and invasion of bladder cancer cells. Hum Cell. 2021;34(2):588–597. DOI:10.1007/s13577-020-00470-3
   PubMed Web of Science ®Google Scholar
• Liu HC, Ma F, Shen Y, et al. Overexpression of SMAR1 enhances radiosensitivity in human breast cancer cell line MCF7 via activation of p53 signaling pathway. Oncol Res. 2014;22(5):293–300. DOI:10.3727/096504015X14424348426035
   PubMed Web of Science ®Google Scholar
• Choksi A, Parulekar A, Pant R, et al. Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1. Cancer Metab. 2021;9(1):16. DOI:10.1186/s40170-021-00252-x
   PubMed Web of Science ®Google Scholar
• Alam A, Taye N, Patel S, et al. SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression. Neoplasia. 2019;21(10):945–962. DOI:10.1016/j.neo.2019.07.002
   PubMed Web of Science ®Google Scholar
• Xu H, Liu T, Li W, et al. SMAR1 attenuates the stemness of osteosarcoma cells via through suppressing ABCG2 transcriptional activity. Environ Toxicol. 2021;36(6):1090–1098. DOI:10.1002/tox.23108
   PubMed Web of Science ®Google Scholar
• Bhattacharya A, et al. SMAR1 repression by pluripotency factors and consequent chemoresistance in breast cancer stem-like cells is reversed by aspirin. Sci Signal. 2020;13(654):eaay6077.
   PubMed Web of Science ®Google Scholar
• Kaul R, Mukherjee S, Ahmed F, et al. Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice. Int J Cancer. 2003;103(5):606–615. DOI:10.1002/ijc.10881
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Adhikary A, Mazumdar M, et al. Capsaicin-Induced activation of p53-SMAR1 auto-regulatory loop down-regulates VEGF in non-small cell lung cancer to restrain angiogenesis. PLoS One. 2014;9(6):e99743. DOI:10.1371/journal.pone.0099743
   PubMed Web of Science ®Google Scholar
• Adhikary A, Chakraborty S, Mazumdar M, et al. Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cells. J Biol Chem. 2014;289(37):25431–25444. DOI:10.1074/jbc.M113.527267
   PubMed Web of Science ®Google Scholar
• Paul D, Ghorai S, Dinesh US, et al. Cdc20 directs proteasome-mediated degradation of the tumor suppressor SMAR1 in higher grades of cancer through the anaphase promoting complex. Cell Death Dis. 2017;8(6):e2882. DOI:10.1038/cddis.2017.270
   PubMedGoogle Scholar
• Taye N, Alam A, Ghorai S, et al. SMAR1 inhibits Wnt/β-catenin signaling and prevents colorectal cancer progression. Oncotarget. 2018;9(30):21322–21336. DOI:10.18632/oncotarget.25093
   PubMedGoogle Scholar
• Huang H, Fan X, Zhang X, et al. LncRNA CARLo-7 facilitates proliferation, migration, invasion, and EMT of bladder cancer cells by regulating Wnt/β-catenin and JAK2/STAT3 signaling pathways. Transl Androl Urol. 2020;9(5):2251–2261. DOI:10.21037/tau-20-1293
   PubMed Web of Science ®Google Scholar
• Wang T, Wang M, Fang S, et al. Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway. Oncotarget. 2017;8(12):18991–19012. DOI:10.18632/oncotarget.15086
   PubMedGoogle Scholar
• Kwak S, Park S-H, Kim S-H, et al. miR-3189-Targeted GLUT3 repression by HDAC2 knockdown inhibits glioblastoma tumorigenesis through regulating glucose metabolism and proliferation. J Exp Clin Cancer Res. 2022;41(1):87. DOI:10.1186/s13046-022-02305-5
   PubMed Web of Science ®Google Scholar
• Rampalli S, Pavithra L, Bhatt A, et al. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex. Mol Cell Biol. 2005;25(19):8415–8429. DOI:10.1128/MCB.25.19.8415-8429.2005
   PubMed Web of Science ®Google Scholar
• Singh K, Sinha S, Malonia SK, et al. Tumor suppressor SMAR1 represses IκBα expression and inhibits p65 transactivation through matrix attachment regions. J Biol Chem. 2009;284(2):1267–1278. DOI:10.1074/jbc.M801088200
   PubMed Web of Science ®Google Scholar
• Pavithra L, Singh S, Sreenath K, et al. Tumor suppressor SMAR1 downregulates Cytokeratin 8 expression by displacing p53 from its cognate site. Int J Biochem Cell Biol. 2009;41(4):862–871. DOI:10.1016/j.biocel.2008.08.038
   PubMed Web of Science ®Google Scholar
• Loh, C-Y., Chai, J., et al. The E-Cadherin and N-Cadherin switch in Epithelial-to-Mesenchymal transition: signaling, therapeutic implications, and challenges. Cells. 2019;8(10):1118. DOI:10.3390/cells8101118
   PubMed Web of Science ®Google Scholar
• Na, T.Y., Schecterson, L., Mendonsa, A M., et al. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc Natl Acad Sci USA. 2020;117(11):5931–5937. DOI:10.1073/pnas.1918167117
   PubMed Web of Science ®Google Scholar
• Vávrová, J., M. Rezáčová. Importance of proapoptotic protein PUMA in cell radioresistance. Folia Biol (Praha). 2014;60(2):53–56.
   PubMed Web of Science ®Google Scholar
• Xu, Z., Shao, J., Zheng, C., et al. The E3 ubiquitin ligase RBCK1 promotes the invasion and metastasis of hepatocellular carcinoma by destroying the PPARγ/PGC1α complex. Am J Cancer Res. 2022;12(3):1372–1392.
   PubMed Web of Science ®Google Scholar
• Lunt, S.Y., M.G. Vander Heiden. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27:441–464.
   PubMed Web of Science ®Google Scholar
• Shen, J., Jin, Z., Lv, H., et al. PFKP is highly expressed in lung cancer and regulates glucose metabolism. Cell Oncol (Dordr). 2020;43(4):617–629. DOI:10.1007/s13402-020-00508-6
   PubMed Web of Science ®Google Scholar
• Mou, J.J., Peng, J., Shi, Y-Y., et al. Mitochondrial DNA content reduction induces aerobic glycolysis and reversible resistance to drug-induced apoptosis in SW480 colorectal cancer cells. Biomed Pharmacother. 2018;103:729–737.
   PubMed Web of Science ®Google Scholar
• Bugter, J.M., N. Fenderico. Mutations and mechanisms of WNT pathway tumour suppressors in cancer. Nat Rev Cancer. 2021;21(1):5–21.
   PubMed Web of Science ®Google Scholar
• Zhan, Y., Zhang, L., Yu, S., et al. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer. J Exp Clin Cancer Res. 2020;39(1):136. DOI:10.1186/s13046-020-01624-9
   PubMed Web of Science ®Google Scholar
• Zhang, M., Du, H., Wang, Lu, et al. Thymoquinone suppresses invasion and metastasis in bladder cancer cells by reversing EMT through the Wnt/β-catenin signaling pathway. Chem Biol Interact. 2020;320:109022.
   PubMed Web of Science ®Google Scholar
• Yoshida, T., Sopko, N A., Kates, M., et al. Three-Dimensional organoid culture reveals involvement of Wnt/β-catenin pathway in proliferation of bladder cancer cells. Oncotarget. 2018;9(13):11060–11070. DOI:10.18632/oncotarget.24308
   PubMedGoogle Scholar
• He, S., S. Tang. WNT/β-Catenin signaling in the development of liver cancers. Biomed Pharmacother. 2020;132:110851.
   PubMed Web of Science ®Google Scholar
• Shang, S., F. Hua, Z.W. Hu. The regulation of β-catenin activity and function in cancer: therapeutic opportunities. Oncotarget. 2017;8(20):33972–33989.
   PubMedGoogle Scholar
• Urakami, S., Shiina, H., Enokida, H., et al. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/β-Catenin signaling pathway. Clin Cancer Res. 2006;12(2):383–391. DOI:10.1158/1078-0432.CCR-05-1344
   PubMed Web of Science ®Google Scholar
• Vallée, A., Y. Lecarpentier. Crosstalk between peroxisome proliferator-activated receptor gamma and the canonical WNT/β-Catenin pathway in chronic inflammation and oxidative stress during carcinogenesis. Front Immunol. 2018;9:745.
   PubMed Web of Science ®Google Scholar
• Fu, J., Liu, Y., Wang, X., et al. Role of DHX33 in c-Myc-induced cancers. Carcinogenesis. 2017;38(6):649–660. DOI:10.1093/carcin/bgx041
   PubMed Web of Science ®Google Scholar
• Sun, J., Zhang, H., Tao, D., et al. CircCDYL inhibits the expression of C-MYC to suppress cell growth and migration in bladder cancer. Artif Cells Nanomed Biotechnol. 2019;47(1):1349–1356. DOI:10.1080/21691401.2019.1596941
   PubMed Web of Science ®Google Scholar
• Mizushima, S., Sasanami, T., Ono, T., et al. Cyclin D1 gene expression is essential for cell cycle progression from the maternal-to-zygotic transition during blastoderm development in Japanese quail. Dev Biol. 2021;476:249–258.
   PubMed Web of Science ®Google Scholar
• Wang, H., J. Wang, B. Zhao. Correlation of p16 and Cyclin D1 expression with the incidence and prognosis of cardiac carcinoma. Oncol Lett. 2019;17(6):4859–4864.
   PubMed Web of Science ®Google Scholar
• Jiao, J., Huang, Lu, Ye, F., et al. Cyclin D1 affects epithelial-mesenchymal transition in epithelial ovarian cancer stem cell-like cells. Onco Targets Ther. 2013;6:667–677.
   PubMed Web of Science ®Google Scholar
• Pavithra, L., Rampalli, S., Sinha, S., et al. Stabilization of SMAR1 mRNA by PGA2 involves a stem–loop structure in the 5′ UTR. Nucleic Acids Res. 2007;35(18):6004–6016. DOI:10.1093/nar/gkm649
   PubMed Web of Science ®Google Scholar
• Wu, Z., Zhou, Z., Zhang, W., et al. MiR-21-5p inhibition attenuates Warburg effect and stemness maintenance in osteosarcoma cells via inactivation of Wnt/β-catenin signaling. Acta Biochim Pol. 2021;68(4):725–732. DOI:10.18388/abp.2020_5631
   PubMed Web of Science ®Google Scholar
• Cha, P.H., Hwang, J-H., Kwak, D-K., et al. APC loss induces Warburg effect via increased PKM2 transcription in colorectal cancer. Br J Cancer. 2021;124(3):634–644. DOI:10.1038/s41416-020-01118-7
   PubMedGoogle Scholar